Wave Life Sciences Ltd. (WVE) NASDAQ
7.32
+0.26(+3.68%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
7.32
+0.26(+3.68%)
Currency In USD
| Market Cap | 2.87B |
| Enterprise Value | 2.28B |
| P/E Ratio | -7.98 |
| PEG Ratio | 0.14 |
| Price/Sales Ratio | 19.61 |
| Price/Book Ratio | 2.86 |
| Enterprise/Revenue | 12.25 |
| Enterprise/EBITDA | -4.83 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -2.56 |
| Operating Margin | -2.74 |
| Return On Assets | -0.31 |
| Return On Equity | -0.56 |
| Revenue | 42.73M |
| Revenue/Share | 0.36 |
| Gross Profit | 33.88M |
| EBITDA | -195.53M |
| Net Income | -204.38M |
| Diluted EPS | -1.21 |
| Total Cash | 544.59M |
| Total Cash/Share | 2.72 |
| Total Debt | 15.72M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 11.26 |
| Book Value Per Share | 2.56 |
| 52-Week Change | -5.3 |
| 52-Week High | 21.73 |
| 52-Week Low | 5.02 |
| Moving Average 50 Days | 10.04 |
| Moving Average 200 Days | 10.21 |
| Average Volume | 4.27M |
| Shares Outstanding | 192.38M |
| % Held by Institutions | 108.95 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |